AMT Stock Analysis: American Tower | NYSE
REIT - Specialty | NYSE, USA | Market Cap: 82.116m USD | 12M Return: -9% | US03027X1000 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 344M
EPS Trend: 71.9%
Qual. Beats: 0
Rev. Trend: -30.0%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
American Tower Corporation (AMT) is one of the largest global real estate investment trusts (REITs) and a leading independent owner, operator, and developer of multitenant communications real estate, incorporated in 1995 in Delaware and headquartered in Boston, Massachusetts. Its core business involves leasing space on communications sites to a diverse tenant base, including wireless service providers, radio and television broadcast companies, wireless data providers, government agencies, and municipalities. The company also operates a data center business, and together these activities are referred to as its property operations.
In addition to its leasing business, American Tower offers tower-related services in the United States, such as site application, zoning and permitting, structural analyses, and construction management. These services primarily support its site leasing operations by facilitating the addition of new tenants and equipment on its sites. As a Telecom Tower REIT, American Tower operates within a sector characterized by long-term, recurring lease contracts with wireless carriers and a capital-intensive infrastructure model focused on owning and managing physical tower and data center assets that are shared among multiple tenants.
- 5G densification drives US tower tenancy and revenue growth
- CoreSite data center segment expansion accelerates recurring revenue mix
- Foreign exchange translation pressures international property segment margins
| Net Income: 3.38b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.39 > 1.0 |
| NWC/Revenue: -52.53% < 20% (prev -22.05%; Δ -30.48% < -1%) |
| CFO/TA 0.09 > 3% & CFO 5.77b > Net Income 3.38b |
| Net Debt (51.0b) to EBITDA (7.03b): 7.26 < 3 |
| Current Ratio: 0.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (466.6m) vs 12m ago -0.46% < -2% |
| Gross Margin: 73.19% > 18% (prev 74.37%; Δ -1.18% > 0.5%) |
| Asset Turnover: 17.22% > 50% (prev 16.09%; Δ 1.13% > 0%) |
| Interest Coverage Ratio: 3.54 > 6 (EBIT TTM 4.94b / Interest Expense TTM 1.40b) |
| A: -0.09 (Total Current Assets 3.12b - Total Current Liabilities 8.87b) / Total Assets 63.3b |
| B: -0.08 (Retained Earnings -5.03b / Total Assets 63.3b) |
| C: 0.08 (EBIT TTM 4.94b / Avg Total Assets 63.5b) |
| D: 0.07 (Book Value of Equity 3.72b / Total Liabilities 53.0b) |
| Altman-Z'' = -0.26 = B |
| DSRI: 0.58 (Receivables 650.9m/1.06b, Revenue 10.9b/10.3b) |
| GMI: 1.02 (GM 74.37% / 73.19%) |
| AQI: 1.25 (AQ_t 0.63 / AQ_t-1 0.50) |
| SGI: 1.07 (Revenue 10.9b / 10.3b) |
| TATA: -0.04 (NI 3.38b - CFO 5.77b) / TA 63.3b) |
| Beneish M = -3.17 (Cap -4..+1) = AA |
As of September 01, 2026, the stock is trading at USD 175.70 with a total of 2,848,147 shares traded. Over the past week, the price has changed by -1.51%, over one month by +1.35%, over three months by -5.41% and over the past year by -8.98%.
Current recommended Stop Loss: 166.40 (which is 5.3% or 2.3 ATR below the current price).
American Tower has received a consensus analysts rating of 4.32. Therefore, it is recommended to buy AMT.
- StrongBuy: 14
- Buy: 5
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 215.7 | 22.8% |
P/E Trailing = 23.9769
P/E Forward = 24.8139
P/S = 7.505
P/B = 21.8167
P/EG = 1.627
Revenue TTM = 10.9b USD
EBIT TTM = 4.94b USD
EBITDA TTM = 7.03b USD
Long Term Debt = 33.8b USD (from longTermDebt, last fiscal year)
Short Term Debt = 5.87b USD (from shortTermDebt, last quarter)
Debt = 52.8b USD (from shortLongTermDebtTotal, last quarter) + Leases 7.81b
Net Debt = 51.0b USD (calculated: Debt 52.8b - CCE 1.76b)
Enterprise Value = 133b USD (82.1b + Debt 52.8b - CCE 1.76b)
Interest Coverage Ratio = 3.54 (Ebit TTM 4.94b / Interest Expense TTM 1.40b)
EV/FCF = 33.62x (Enterprise Value 133b / FCF TTM 3.96b)
FCF Yield = 2.97% (FCF TTM 3.96b / Enterprise Value 133b)
FCF Margin = 36.19% (FCF TTM 3.96b / Revenue TTM 10.9b)
Net Margin = 30.88% (Net Income TTM 3.38b / Revenue TTM 10.9b)
Gross Margin = 73.19% ((Revenue TTM 10.9b - Cost of Revenue TTM 2.93b) / Revenue TTM)
Gross Margin QoQ = 73.03% (prev 73.91%)
Tobins Q-Ratio = 2.10 (Enterprise Value 133b / Total Assets 63.3b)
Interest Expense / Debt = 2.64% (Interest Expense 1.40b / Debt 52.8b)
Taxrate = 10.68% (415.4m / 3.89b)
NOPAT = 4.41b (EBIT 4.94b * (1 - 10.68%))
Current Ratio = 0.35 (Total Current Assets 3.12b / Total Current Liabilities 8.87b)
Debt / Equity = 14.19 (Debt 52.8b / totalStockholderEquity, last quarter 3.72b)
Debt / EBITDA = 7.26 (Net Debt 51.0b / EBITDA 7.03b)
Debt / FCF = 12.89 (Net Debt 51.0b / FCF TTM 3.96b)
Total Stockholder Equity = 3.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.32% (Net Income 3.38b / Total Assets 63.3b)
RoE = 90.23% (Net Income TTM 3.38b / Total Stockholder Equity 3.74b)
RoCE = 13.14% (EBIT 4.94b / Capital Employed (Equity 3.74b + L.T.Debt 33.8b))
RoIC = 7.38% (NOPAT 4.41b / Invested Capital 59.8b)
WACC = 3.69% (E(82.1b)/V(135b) * Re(4.55%) + D(52.8b)/V(135b) * Rd(2.64%) * (1-Tc(0.11)))
Discount Rate = 4.55% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -22.48 | Cagr: -0.10%
[DCF] Terminal Value 76.18% ; FCFF base≈3.87b ; Y1≈4.08b ; Y5≈4.75b
[DCF] Fair Price = 47.42 (EV 73.1b - Net Debt 51.0b = Equity 22.1b / Shares 466.0m; r=8.35% [WACC [floored]]; 5y FCF grow 5.85% → 2.50% )
EPS Correlation: 71.92 | EPS CAGR: 31.96% | SUE: 0.09 | # QB: 0
Revenue Correlation: -30.00 | Revenue CAGR: -0.75% | SUE: 0.35 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.64 | Chg30d=+3.54% | Revisions=+70% | Analysts=7
EPS current Year (2026-12-31): EPS=6.98 | Chg30d=+5.79% | Revisions=+70% | GrowthEPS=+29.3% | GrowthRev=+3.4%
EPS next Year (2027-12-31): EPS=7.01 | Chg30d=+1.97% | Revisions=+0% | GrowthEPS=+0.4% | GrowthRev=+3.5%
[Analyst] Revisions Ratio: +56% (up=18, down=4)